John Driscoll, RIS Rx Board Chairman

Thrilled to welcome John Driscoll as Chairman of the RIS Rx Board of Directors.

John’s impact across the healthcare landscape is unmatched.

He previously led CareCentrix as CEO, founded and served as Chair of the Surescripts e-prescribing network, scaled U.S. Healthcare operations at Walgreens Boots Alliance, and held senior roles at Medco Health Solutions and Castlight Health. Today, he serves as Chairman at Waystar, UConn Health, and Magnit Global, continuing to shape how care is delivered and paid for in the U.S.

His ability to navigate payer, provider, and tech ecosystems brings rare perspective and precision that will help us continue to solve one of pharma’s most entrenched problems: Gross-to-Net Leakage Blind Spots.

Grateful to have his counsel during our next stage of growth.

Check out the full press release here.

Gerard Rivera
Gerard Rivera
Co-founder & CEO

Gerard serves as CEO of RIS Rx, which he co-founded in 2020. In partnership with the RIS Rx executive team, Gerard is pioneering gross-to-net (GTN) revenue protection with direct impact to millions of patients and the pharmaceutical manufacturers that support them. His background spans frontline pharmacy, patient access & affordability operations, with leadership experience across multiple pharmacy services and healthcare organizations. He earned his PharmD from Loma Linda University. Read More